Search

everythinglearnresearchcommunity

for

Search:↓

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

Intravenous methylprednisolone helped over half of alopecia areata patients regrow hair, but many relapsed.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

Sorafenib causes skin reactions by increasing the number and activity of skin mast cells.

JAK inhibitors might help treat alopecia areata.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Two women experienced temporary hair loss and other side effects from imiquimod treatment for cervical issues, which stopped after ending the treatment.

The new microneedle treatment could be a more effective and convenient option for hair loss.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

Combining either fractional CO2 laser or microneedling with 5-FU is more effective for treating vitiligo.

A new patch can deliver stable antibodies over time for potential HIV treatment.

Transplanting skin cells is a safe, effective, and affordable treatment for vitiligo.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

The combined treatment helped prevent hair loss and promoted full hair regrowth in breast cancer patients after chemotherapy.

Patients with advanced breast cancer prioritize quality of life, overall survival, and progression-free survival in treatment decisions.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

IL-27 may help prevent hair loss by creating immune-suppressing cells.

The new drug delivery system improves vitiligo treatment by enhancing melanocyte activity and viability.

Combining mesotherapy with systemic treatments effectively improves alopecia universalis treatment.

COVID-19 vaccination may trigger recurrence of cutaneous T-cell lymphoma in some patients.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

A woman's hair loss was likely caused by a cream used for skin treatment and improved after she stopped using it.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Combining hair transplantation with microneedling or laser and UV light may help treat tough vitiligo on hands and feet, with microneedling being affordable and easy to learn.